Customers with these devices on hand are asked to return them right away. No serious injuries have been reported at this time, but the presence of residual particulates can lead to such side effects as pulmonary embolism and deep vein thrombosis.

Boston Scientific manufactured these devices from 2002 to 2021, and approximately 354,000 are still in use. It is recommended that clinicians look for early signs of this issue during scheduled follow-up appointments.

The question of legal responsibility for AI gone wrong in healthcare remains unsettled. The only sure thing is a lot of finger pointing. 

Wearable health devices outfitted with AI seem poised to transition from consumer novelties to an integral layer of U.S. public-health intelligence. 

SCAI and HRS have collaborated on new guidelines designed to help clinicians make the safest, smartest treatment decisions possible.

Or maybe the White House’s AI Action Plan will spur a mix of positive opportunities, negative challenges—and neutral adjustments.

No single CMS strategy has proven an inarguable success at delivering significant cost savings while optimizing patient outcomes and minimizing clinical risks. Two researchers think they’ve found a way. 

PressGaney market researchers offer three observations on the technology’s potential for optimizing patient satisfaction—and, with it, subsequent ‘PX’ scores.